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Abstract. Objective: Requirements for cytokines and
adhesion molecules for perititoneal neutrophil recruitment
during glycogen-induced peritonitis in rats were system-
atically defined.
Subjects:Male Long Evans rats (275–300 g).
Methods: Four hours after intraperitoneal injection of 25 mg
oyster glycogen, neutrophilic exudates were harvested.
Effects of blocking reagents (injected intravenously) to rat
E-, L- and P-selectins,b1 (VLA-4) and b2 integrins (LFA-1
and Mac-1), ICAM-1, and the cytokines TNFa, IL-1 and IL-8
were assessed.
Results:Administration of synthetic sialyl Lewisx oligosac-
charide reduced neutrophil recruitment to the peritoneum
by 26%. Antibody to E-selectin reduced neutrophil accumu-
lation by 71%, while anti-L-selectin reduced neutrophil
accumulation by 59%, and anti-P-selectin was without an
effect. Similar patterns of inhibition were found when
selectin-Ig chimeras were employed. Antibodies to LFA-1
(CD11a), Mac-1 (CD11b) or CD18 reduced neutrophil
accumulation by 62%, 59% and 86%, respectively, while
anti-VLA-4 was without effect. Anti-ICAM-1 reduced cell
influx by 65%. IL-1 receptor antagonist and antibodies to IL-
1 and human IL-8 reduced neutrophil accumulation by 43%,
40% and 62%, respectively. Unexpectedly, blockade of
TNFa had no effect.
Conclusions: These studies identify requirements for
selectins,b2 integrins, IL-1 and a rat chemokine(s) similar
to human IL-8 for neutrophil recruitment during glycogen-
induced peritonitis. The lack of participation of VLA-4,
P-selectin and TNFa suggests organ-specific cytokine
and adhesion molecule requirements for neutrophil
recruitment.
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Introduction
Neutrophil adhesion to the vascular endothelium and
subsequent migration to an inflammatory site is a highly
regulated process requiring the coordinated participation of
cytokines (including chemokines) and leukocyte and
endothelial adhesion molecules. Neutrophil recruitment
into different organs often involves a repertoire of cytokines
and adhesion molecules, and in some cases there are
suggestions that there are tissue-specific roles for these
mediators. Peritonitis induced by intraperitoneal injection
of glycogen results in a large accumulation of neutrophils.
It has been demonstrated that neutrophil recruitment
under these conditions is dependent upon participation of
L-selectin, since blockade of L-selectin with blocking
antibody or L-selectin-Ig chimera reduces neutrophil accu-
mulation [1, 2]. In P-selectin and/or ICAM-1 knock-out
mice, these adhesion molecules have been described as
participating in thioglycolate-induced peritoneal exudates
[3, 4]. Others have suggested that neutrophil accumulation
under these conditions requires a combination of both P- and
E-selectin [5]. In other tissues such as lung, it has been
shown that depending on the bacterial agent present,
neutrophil accumulation may be CD18-dependent or inde-
pendent [6]. Our own studies have demonstrated that
neutrophil accumulation in lung following deposition of
IgG immune complexes is dependent on CD11a, ICAM-1
and E-selectin, while CD11b plays a role in facilitating
TNFa production by lung macrophages [7–9]. In lung,
neutrophil accumulation also requires the participation of
TNFa, IL-1, and IL-8 [10–12]. In contrast, in the dermis,
neutrophil accumulation in response to vascular deposition
of IgG immune complexes requires IL-1 but not TNFa [13].
In the current studies, we sought to further delineate tissue-
specific mechanisms of neutrophil recruitment by system-
atically defining cytokine and adhesion molecule require-
ments in glycogen-induced peritonitis. Comparisons and
contrasts to cytokine and adhesion molecules requirements
in other organs of rats are noted.
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Materials and methods
Glycogen-induced peritonitis
Oyster glycogen (Sigma, St. Louis, MO, USA) was dissolved in
phosphate buffered saline (pH 7.4) to a final concentration of 1 mg/ml.
A total of 25 ml were injected intraperitoneally into male Long
Evans rats (275–300 g) and the peritoneal exudates were harvested 4 h
later. Exudate cells were determined to be >95% neutrophils by
microcytometry.
Synthetic sialyl LewisX oligosaccharides
Fucosylated and non-fucosylated versions of sialyl Lewisx were
employed in order to have a selectin-blocking intervention as described
elsewhere [14, 15]. For selectin blockade, the fucosylated pentasac-
charide version (SLX) was employed. As a negative control, the non-
selectin-reactive, non-fucosylated form of SLX, sialyl-N-acetyllacto-
samine (SLN), was employed. The oligosaccharides were dissolved in
PBS. A total of 200mg was injected intraperitoneally with the glycogen
preparation, followed by intravenous injections of 100mg (in 0.5 ml)
2.5, 3.0 and 3.5 h after injection of glycogen. Using SLX, this
dose schedule effectively blocks selectin-mediated lung neutrophil
accumulation after intrapulmonary deposition of IgG immune complexes
[15].
Selectin chimeras
The E-, L- and P-selectin-Ig chimeras were made in 293 cells and
purified as described previously [2, 16]. The human CD4-Ig chimera
was made as described by Capon et al. [17] and was used as an
irrelevant control. The L-selectin-Ig chimera was of murine origin and
the E- and P-selectin-Ig chimeras were of human origin [2,14]. A
total of 2 mg E-, L-, or P-selectin-Ig chimera was injected intravenously
5 min before intraperitoneal injection of glycogen. When infused
intravenously, none of the selectin chimeras cause neutropenia [18].
Blocking antibodies
The blocking antibodies and the times and routes of infusion were based
on previous studies in which interventions were employed to block
neutrophil accumulation in lung 4 hours after intrapulmonary deposi-
tion of IgG immune complexes [7–12]. Anti-rat VLA-4 (CD49d), clone
TA-2, of the IgG1 subclass, is reactive with thea4chain ofb1 integrin
[19]. The antibody was infused intravenously in 0.25 ml (800mg) just
prior to glycogen injection. This protocol results in blocking of delayed-
type hypersensitivity skin reactions in rats [20]. Anti-rat LFA-1
(CD11a), clone WT-1, of the murine IgG2a subclass [21], and anti-rat
Mac-1 (CD11b), clone 1B6c, of the murine IgG1 subclass [22], were
infused intravenously (200mg) just prior to glycogen injection. Anti-rat
CD18, clone CL26, of the IgG1 subclass, was used as F(ab
0)2 fragments
as intact CL26 antibody has been shown to induce neutropenia [7].
Anti-rat ICAM-1, clone 1A29, of the IgG1 subclass [23], was used as
F(ab0)2 fragments, as intact 1A29 antibody does not block neutrophil
accumulation in lung [7]. Anti-E-selectin, clone CL3, a murine
monoclonal IgG1 to human E-selectin with cross-reactivity to rat E-
selectin was used as F(ab0)2 fragments, since intact CL3 neither blocked
in vitro neutrophil adhesion to TNFa stimulated endothelial cells nor
did it block neutrophil accumulation in rat lung [8]. Anti-rat L-selectin,
clone HRL1, of the IgG1 subclass, was prepared as described previously
[24]. HRL1 was used as F(ab0)2 fragments since the intact antibody
causes neutropenia [24]. Anti-P-selectin, clone PB1.3, a murine IgG1
monoclonal antibody to human P-selectin with cross-reactivity to rat P-
selectin [25], was injected intravenously (200mg) just prior to glycogen
injection. All antibodies used as F(ab0)2 fragments were administered
intravenously (67mg each) 2.5, 3.0 and 3.5 h after peritoneal instillation
of glycogen. Antibodies to murine TNFa and IL-1 (goat polyclonal
IgG) cross-reacted with rat IL-1 and TNFa [10, 11], and were infused
intravenously (1.0 ml) as whole goat serum just prior to injection of
glycogen. Murine monoclonal antibody (IgG1) to human IL-8 (DM/C7)
has been shown to be cross-reactive with a rat epitope and to suppress
neutrophil influx into lung following intrapulmonary deposition of IgG
immune complexes [12]. However, precisely what rat chemokine(s)
DM/C7 reacts with has not been determined. A total of 200mg DM/C7
were infused intravenously just prior to glycogen injection. IL-1
receptor antagonist (IL-1Ra) was a human recombinant protein shown
to block binding of IL-1 to receptors on rat T-cells [26]. IL-1Ra (2 mg/
kg) was injected subcutaneously just prior to glycogen injection. This
antagonist has been shown to block IL-1 dependent lung inflammatory
reactions in rats [13].
Statistical analyses
All values are expressed as mean6 SEM. Data were analyzed with a
one-way analysis of variance and individual group means were then
compared with a Tukey’s test. Differences were considered significant
when p< 0.05. For calculations of percent change, negative control
values were subtracted from positive control and treatment group
values.
Results
Involvement of selectins for peritoneal recruitment of
neutrophils
Roles for selectins in peritoneal neutrophil recruitment were
provisionally evaluated using the P- and L-selectin-reactive
oligosaccharide, SLX. Systemic administration of SLX
reduced neutrophil numbers from 1386 2.8×106 neutro-
phils in positive controls receiving the non-selectin-reactive
oligosaccharide SLN, to 1056 2.9× 106 neutrophils, repre-
senting a 26% decrease (p < 0.01). To further delineate roles
for E-, L- and P-selectins, blocking antibodies and selectin-Ig
chimeras were employed. Blocking antibodies and chimeras
to E-, L- and P-selectins were administered in dose schedules
known to interfere with lung recruitment of neutrophils
[8, 18, 24, 25]. Anti-E-selectin and anti-L-selectin reduced
glycogen-induced peritoneal neutrophil accumulation by 71%
and 59%, respectively, while anti-P-selectin had no effect
(Fig. 1A). When selectin-Ig chimeras were used, similar
inhibitory patterns were observed. Administration of E- or L-
selectin-Ig’s reduced peritoneal neutrophil accumulation by
33% and 50%, respectively, and P-selectin-Ig had no effect
(Fig. 1B).
Involvement ofb1 andb2 integrins and ICAM-1 for
peritoneal neutrophil recruitment
Infusion of antibody to the ratb1 integrin VLA-4 (CD49d)
had no effect on peritoneal accumulation of neutrophils
(Fig. 2A), even though this antibody is known to block the
influx of mononuclear cells in delayed hypersensitivity
reactions in rats [20]. Antibodies to the ratb2 integrins LFA-
1 (CD11a), Mac-1 (CD11b) and theb2 common chain
(CD18) reduced neutrophil accumulation by 62% , 59% and
86%, respectively (Fig. 2A). In view of the requirements for
b2 integrins, treatment with blocking antibody to the
endothelial adhesion molecule ICAM-1 was employed in a
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separate experiment. Consistent with inhibitory effects ofb2
integrin blockade, administration of F(ab0)2 anti-ICAM-1
reduced neutrophil accumulation by 65% (Fig. 2B).
Requirements for cytokines for peritoneal recruitment of
neutrophils
Since endothelial cell upregulation of adhesion molecules by
cytokines (i.e., TNFa, IL-1) is essential for lung accumula-
tion of neutrophils following deposition of IgG immune
complexes [27], roles of TNFa and IL-1 for peritoneal
recruitment of neutrophils was examined using blocking
antibodies or receptor antagonist. Unexpectedly, adminis-
tration of antibody to TNFa had no effect on neutrophil
recruitment to the peritoneum (Fig. 3). In contrast, antibodies
to IL-1 reduced neutrophil accumulation by 40% (Fig. 3).
The ability of anti-IL-1 to reduce glycogen-induced
peritoneal accumulation of neutrophils was confirmed by
treatment of rats with IL-1Ra. Administration of IL-1Ra
reduced peritoneal neutrophil counts by 43%. To investigate
a role of CXC chemokines in glycogen-induced peritoneal
neutrophil recruitment, rats were treated with antibody to
human IL-8. This antibody has been shown to react with a rat
epitope and reduce lung accumulation of neutrophils in rats
after IgG immune complex deposition [12]. Administration
of anti-human IL-8 caused a 62% reduction in peritoneal
neutrophil accumulation (Fig. 3). Thus, glycogen-induced
peritoneal accumulation of rat neutrophils requires IL-1 and
a rat homologue of IL-8, but not TNFa.
Discussion
These studies demonstrate that peritoneal recruitment of
neutrophils during glycogen-induced peritonitis is dependent
upon of E- and L-selectins (Fig. 1). The requirement for
E-selectin implies that the presence of glycogen in the
peritoneal cavity somehow results in upregulation of
vascular E-selectin. In neutrophil-mediated lung injury
induced by IgG immune complexes, lung TNFa and IL-1
production causes upregulation of pulmonary vascular
adhesion molecules including ICAM-1 and E-selectin
[8, 11, 27]. In the current studies, blockade of TNFa had
no effect on neutrophil recruitment to the peritoneum,
uggesting that IL-1 production may be linked to vascular
upregulation of E-selectin and ICAM-1 in this model.
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Fig. 1. Effects of selectin blockade on glycogen-induced peritoneal
recruitment of neutrophils. Blocking antibodies (A), or selectin-Ig
chimeras (B) were administered as indicated in Materials and methods.
Negative controls (open bar) received 25 ml PBS i.p.; positive controls
and treatment groups (hatched bars) received 25 mg oyster glycogen i.p.
Negative and positive controls received either irrelevant IgG F(ab0)2
fragments (A), or CD4-chimera (B). For each group, n¼ 4–8.
*p < 0:01 compared to positive control group.
Fig. 2. Effects of blocking antibodies tob1 and b2 integrins (A), or
ICAM-1 (B) on glycogen-induced peritoneal recruitment of neutro-
phils. Negative controls (open bar) received 25 ml PBS i.p.; positive
controls and treatment groups (hatched bars) received 25 mg oyster
glycogen i.p. Negative and positive controls received irrelevant IgG
F(ab0)2 fragments. For each group, n¼ 4–8. *p< 0:01 compared to
positive control group.
Similarly, the requirement for L-selectin could be explained
either by the fact that injection of glycogen leads to
upregulation of a vascular endothelial ligand for L-selectin,
or that L-selectin, through its SLX content, is reactive with
endothelial E- and P-selectins, which has been suggested by
other studies [28, 29]. However, a role for P-selectin was not
identified in glycogen-induced peritoneal accumulation of
neutrophils (Fig. 1). The failure to detect a role for P-selectin
is not likely due to insufficient availability of blocking
reagents, since both anti-P-selectin and P-selectin-Ig chi-
meric protein have relatively long half-lives in the circula-
tion and in a model of lung injury induced by cobra venom
factor in rats these treatment protocols efficiently reduce
lung neutrophil accumulation [25]. Since P-selectin is
transiently expressed on endothelial cells, a role for P-
selectin in this model of inflammation may well have been
missed because of the relatively long time course (4 h) for the
full development of this inflammatory reaction. This is in
contrast to mice lacking the gene encoding P-selectin, in
which numbers of thioglycolate-induced peritoneal neutro-
phils have been reported to be reduced [3].
Selectin-mediated leukocyte adhesion is prerequisite for
leukocyte integrin interactions with counter receptors on
the vascular endothelium. Our data show that peritoneal
recruitment of neutrophils is independent of theb1 integrin
VLA-4. This finding is not surprising, in as much as
neutrophils express little, if any, VLA-4. However, neutro-
phils abundantly express theb2 integrins, LFA-1 (CD11a) and
Mac-1 (CD11b). The data described above indicate that both
LFA-1 and Mac-1 are required for peritoneal accumulation of
neutrophils. ICAM-1 is a primary endothelial counter-receptor
for theseb2 integrins and blockade of ICAM-1 was also highly
inhibitory for the accumulation of neutrophils. Endothelial
cell expression of ICAM-1 is upregulated by proinflammatory
cytokines including TNFa and IL-1 [27]. In the current model
it appears that intraperitoneal production of IL-1, but not
TNFa, contributes to upregulation of ICAM-1, increasing
neutrophil adhesion and transmigration.
The requirement for IL-1 and exclusion of a role for
TNFa in the peritoneal recruitment of neutrophils during
glycogen-induced peritonitis is in contrast to neutrophil
accumulation in lung following intrapulmonary deposition
of IgG immune complexes which requires both TNFa and
IL-1 [10, 11]. In the case of glomerular deposition of IgG
immune complexes (in a model of acute nephrotoxic
nephritis) in rats, this leads to an accumulation of neutrophils
that requires TNFa but is independent of IL-1 [30]. The rat
glomerular vasculature appears to be responsive to the renal
arterial infusion of TNFa, resulting in the upregulation of
glomerular adhesion molecules (E-selectin, ICAM-1,
VCAM-1), but under similar conditions the infusion of IL-
1 has little, if any, effect on the glomerular vasculature [30].
Accordingly, both the expression of TNFa and IL-1 as well
as the vascular response to these cytokines appears to be
variable, dependent on the vascular bed and the nature of the
stimulus. The differential requirements for TNFa and IL-1 in
the renal glomerular model are similar to those observed in
other studies in which the recruitment of neutrophils into rat
dermis following intradermal deposition of IgG immune
complexes was shown to require IL-1 but not TNFa [13]. In
those studies the lack of a role for TNFa appears to be
related, not to the refractoriness of the dermal vasculature to
TNFa, but rather, to the lack of intradermal expression of
TNFa following vascular deposition of IgG immune
complexes. It may be that rat macrophages or other cell
types in skin, renal glomerulus and peritoneum can respond
to stimuli with elaboration of IL-1, but not TNFa, in contrast
o other areas such as lung. It seems likely that IL-1 is a key
mediator in the peritoneal recruitment of neutrophils through
upregulation of E-selectin and ICAM-1.
Finally, the ability of anti-human IL-8 to reduce
neutrophil accumulation during glycogen-induced peritonitis
is similar to previous studies in which the same antibody
substantially reduced neutrophil influx into dermal or
pulmonary inflammatory sites [12, 31]. Our current data
suggest that antibody to human IL-8 (DM/C7) cross-reacts
with a rat product that has functional role as a proinflamma-
tory mediator required for peritoneal neutrophil recruitment
as in lung. The DM/C7 antibody is reactive with a rat epitope
that appears to be homologous to human IL-8, although our
attempts to identify this product by immunoaffinity techni-
ques have, to date, been unsuccessful. Notwithstanding, our
data suggest that an IL-8-like CXC chemokine plays a
central role in the recruitment of neutrophils during
peritoneal inflammation.
In summary, the data in this report identify adhesion
molecule and cytokine requirements for neutrophil recruit-
ment during glycogen-induced peritonitis. Accumulation of
neutrophils in the peritoneum appears to be dependent upon
L-selectin and theb2 integrins LFA-1 and Mac-1 on
neutrophils, and E-selectin and ICAM-1 on the endothelium.
Additionally, neutrophil recruitment to the peritoneum
requires the participation of IL-1 and an IL-8-like molecule,
but not TNFa. Thus, these findings demonstrate important
organ-specific roles for cytokines and adhesion molecules in
the in vivo recruitment of neutrophils.
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Fig. 3. Effects of cytokine blockade on glycogen-induced peritoneal
recruitment of neutrophils. Negative controls (open bar) received 25 ml
PBS i.p.; positive controls and treatment groups (hatched bars) received
25 mg oyster glycogen i.p. Negative and positive controls received
irrelevant IgG antibody. For each group, n¼ 4–8. *p< 0:01 compared
to positive control group.
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